Wednesday, 28 September 2022

Increased risk of cancer in children born to mothers with epilepsy using high-dose folic acid during pregnancy

High-dose folic acid is protective against congenital malformations if the mother is at particular risk of having a child with congenital malformations. Treatment with antiseizure medication in pregnancy is associated with risk of congenital malformations in the children, and women with epilepsy are therefore often recommended a supplementary high dose of folic acid (4–5 mg daily) before and during pregnancy. However, some studies have raised concern that folic acid can increase the risk of cancer not only in the mother, but in the child when exposed during pregnancy.